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Breast milk is considered the gold standard of infant nutrition, but some infants around the world
lack access to it due to maternal health complications or other considerations. Human breast milk
banks do exist to try to alleviate this problem, but most are underfunded and have high
operational costs, making it difficult for some infants to obtain safe, reliable donated breast milk.
Existing methods of testing breast milk are expensive, so the MilkGuard project was
conceptualized in 2017 as a fast, economical, and highly usable bacterial contamination detection
system. Prior to this year, previous MilkGuard teams had developed a system that was faster and
more affordable than prior methods, but its main drawbacks were that it was difficult to use and
that it lacked the sensitivity to detect low Escherichia coli (E. coli) contamination levels. To
ameliorate these drawbacks, our goals for this year were 1) to improve MilkGuard’s sensitivity to
the Human Milk Banking Association of North America’s (HMBANA) lower limit of detection
standard of 104 CFU/mL, 2) to increase the ease of the assay process, and 3) to achieve these
objectives in an economical and environmentally-friendly way.
Through COMSOL Multiphysics software simulations, we proved the possibility of
realistically optimizing biosensor parameters on a computer. Since the simulations were virtual,
we discovered an optimal biosensor configuration without the need to purchase, manufacture,
and test hundreds of physical sensors. Future teams can quickly confirm these results by building
a physical sensor in the lab. We also developed the MilkGuard app, which greatly simplifies the
colorimetric analysis process for the user. This mobile app uses our improved color-analysis
algorithm which improves detection sensitivity around the HMBANA’s lowered limit of
detection standard, given the same image data to analyze. The efficacy of our new color analysis
algorithm can be confirmed by future teams in the lab, and our current regression curve can be
made more robust with a larger sample size.
Taken together, our developments this year have increased the usability and sensitivity of
the MilkGuard system, which can improve bacterial contamination testing by milk banks and
move one step closer to equitable access to safe breast milk for infants around the world.
Key Words: [milk bank], [breast milk], [infant health], [infant safety], [bacteriological testing],
[E. coli detection], [hydrogel biosensor], [alginate hydrogel]
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Chapter 1: Introduction
1.1 Importance of Breast Milk
Breast milk is considered the gold standard of infant nutrition worldwide [1]. Breast milk
provides infants with nutrients and energy needed during their early life, and contains antibodies
that help guard against common childhood illnesses [3]. Breastfeeding has been linked to
enhanced cognitive development and decreased infant mortality. However, access to breast milk
remains a challenge for many mothers and babies worldwide. The World Health Organization
estimates that 820,000 children around the world could have been saved if optimally breastfed
[4].
1.2 Lack of Access to Breast Milk
Some mothers are advised against, or unable to breastfeed. This includes women infected
with HIV or human T-lymphotropic virus (type I or type II). Women taking HIV medication or
cancer chemotherapy agents should also avoid breastfeeding their infant. Other conditions, such
as diabetes and thyroid conditions make it challenging for women to produce or pump enough
milk for their infants [5]. This challenge has led to the emergence of breast milk banks
worldwide that aim to provide mothers and infants with sufficient, reliable, and safe access to
donated human breast milk (DHBM).
1.3 Milk Bank Operation and Challenges
To ensure infant safety, milk banks should maintain rigorous pasteurization and
bacteriological testing procedures [4]. The Human Milk Banking Association of North America’s
(HMBANA) standards requires that a milk bank’s medical director, staff, and board of directors
include healthcare professionals. All staff must have food safety, food processing, Preventive
Controls Qualified Individual (PCQI) training, and must participate in continuing education.
Breast milk donors must be screened verbally for (at minimum) HIV-1 and -2, HTLV-1 and -2,
hepatitis C, hepatitis B, and syphilis and must be instructed on safe expression techniques.
DHBM is accepted only if it was been expressed in the previous 36 hours or was placed in a
freezer within 36 hours of expression. All milk banks should follow applicable safety and
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quality-assurance processing procedures as defined by the Current Good Manufacturing Practice,
FDA, and other governing bodies. Milk banks maintain calibrated pasteurizers, freezers,
refrigerators, dish machines, and thermometers. Upon receiving milk from a donor, the donation
is recorded, thawed (if necessary), pooled, and mixed under aseptic technique. Pooled DHBM is
then strained with a food-grade filter and stored in food-grade plastic bottles. Each bottle is
pasteurized at 62.5°C for 30 minutes then rapidly chilled. At this point, one bottle from each
batch must be sent to an external lab for bacteriological testing. The remainder of the batch must
be placed under refrigeration while awaiting test results. Once the bottle sent for testing passes,
the entire batch can be distributed to mothers and infants [6].
The rigorous bacteriological testing procedures makes the DHBM at milk banks safer
than the milk purchased from internet sources or from informal exchanges [7]. However,
bacteriological testing is also expensive ($35-81 plus additional labor costs to test 100-200 oz of
DHBM [8]) and time consuming [9]. These high costs limit infant access to breast milk [2].
1.4 The MilkGuard Solution
To address current shortcomings and improve infant health through enhanced access to optimal
nutrition (human breast milk), MilkGuard has developed a biodegradable, alginate hydrogel
biosensor that colorimetrically detects the presence of Escherichia coli (E. coli) in DHBM [3].
The goal of the MilkGuard biosensor and associated analysis is to create a safe, reliable,
affordable, environmentally-friendly, and intuitive way for milk banks to perform bacteriological
testing on donated human breast milk within their facilities. In-house testing with an affordable
product that does not require lab-access will cut the cost of milk bank operation and therefore
reduce the price tag that is currently placed on the safest, most reliable option for mothers who
are unable to breastfeed their infants.
11
Chapter 2: Review of Field
2.1 Current Solutions for Bacteriological Testing
Currently, few available options for the bacteriological testing of breast milk. In addition to the
standard bacteriological testing regiment at external laboratory facilities, there are two
commercially available testing products. These are discussed below.
Lactation Labs offers a breast milk analysis service for lactating mothers. Lactation Labs
markets their product to mothers as a convenient way to analyze the nutritional content of their
milk from home. A mother receives a Lactation Labs sample collection kit at home. She then
uses the kit to collect a sample of her milk. This sample is then shipped back to Lactation Labs
where it is analyzed in a laboratory. Once lab tests are completed and results are compiled, the
mother receives a full report of her analysis in her email inbox. Results are typically available in
1–3 weeks, depending on the type of test ordered. Kits are available in basic, standard, and
premium options, and cost between $99 and $349. While this model of testing is novel for its
direct involvement with mothers, Lactation Labs does not currently offer bacteriological testing
[4].
My Milk Lab Mylee is known for its electrochemical breast milk sensor. Released to
market in 2019, Mylee analyzes the composition of HBM and uploads this information to a
mobile application. The device uses a few drops of breast milk to analyze the electrochemical
properties of the mother’s milk. These properties are correlated to existing HBM nutritional data,
gathered and generated by Mylee. Results of the analysis are posted to the Mylee mobile
application for the mother to view. The Mylee microdevices cost $349 each, but can be reused by
a mother repeatedly. The device does not currently offer bacteriological testing of breast milk.
However, My Milk Lab does offer separate breast milk bacteriological testing kits. The process
of breast milk collection and analysis for these testing kits is similar to that of Lactation Lab’s




Biosensor computer-aided design (CAD) modeling has been previously used in bacterial
detection applications, such as COMSOL Multiphysics modeling of graphene field-effect
transistor biosensors for bacterial detection [6], electrochemical impedance spectroscopy
detection for polarizable bacteria [7], and bioluminescent sensors for both Aliivibrio fischeri [8]
and foodborne bacterial ATP [9]. COMSOL models have also been used to explore the optimal
geometry of microfluidic biosensors for detecting food-bourne salmonella [10] and interdigitated
electrode sensors [11], which can be used for detection of S. aureus [12] and E. coli [13].
General colorimetric analysis methods have applications in food safety [14], specifically
of dairy products [15]; point-of-care diagnostics [16] such as the diagnosis of kidney failure from
levels of creatinine [17]; and environmental monitoring [18]. Biomedical applications of
smartphone-based technologies include rapid blood hemocytometry and analysis [19-21],
parasite detection [22], histological classification [23], skin tumor diagnostics [24],
ophthalmology [25], hepatology [26], and other global health applications [27]. Biomedical
smartphone applications specifically using colorimetry include ones for methamphetamine [28]
or salivary glucose detection. Smartphone applications also exist that test for milk tetracycline
residues [29] or hormone levels in milk [30].
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Chapter 3: Previous Achievements & Current
Challenges
3.1 Colorimetric Reaction
The MilkGuard biosensor is an alginate-based hydrogel biosensor with encapsulated
5-bromo-4-chloro-3-indolyl-β-D-galactopyranoside (x-gal). In low glucose, high-lactose
environments like DHBM, E. coli produces β-galactosidase for the hydrolysis of lactose..
β-galactosidase will also hydrolyze X-gal. The product of the X-gal hydrolysis spontaneously
dimerizes into an intense, visible blue precipitate that can be used for colorimetric analyses [See
Figure 1].
Figure 1: Reaction schematic for X-gal hydrolysis in the presence of β-galactosidase. The blue precipitate product is
used in our assay for colorimetric analysis.
The reaction between β-galactosidase and X-gal is usually used in blue-white colony screening
in recombinant DNA techniques, but previous MilkGuard teams chose to use this reaction to
develop a colorimetric assay to detect the presence of E Coli in breast milk. If present in a
donated milk sample, E. coli will produce beta galactosidase, which in turn hydrolyzes X-gal and
produces a visible blue precipitate that can be quantified.
3.2 Alginate Hydrogel
Previous teams developed a cost-effective, biodegradable alginate hydrogel biosensor for the
MilkGuard system. The hydrogel microcapsules are fabricated with a autoclaved 3% (w/v)
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solution of alginate and 0.9% (w/v) NaCl as a solvent. Previous observation indicates that
sterilization of the alginate materials is necessary to eliminate yeast contamination that produces
false positive results [3]. After sterilization and mixing, 1 mL aliquots of the alginate solution are
spiked with X-gal. The concentration of X-gal has varied throughout the history of MilkGuard
and will need to be finalized in future work. The solution is then stirred and extruded through a
standard 304 SS 18 gauge needle based on principles of ionotropic gelation [31]. The
microcapsules are dropped into a CaCl2 solution to facilitate cross linking and washed after 30
minutes of incubation with an NaCl solution.
3.3 Biosensor Geometry
The MilkGuard biosensors were originally paper-based. The porous, filter-paper sensor with
reagents deposited onto its surface is an extremely low-cost model [32]. However, alginate
hydrogel is much easier to manufacture and uniformly produce. Alginate hydrogel is also
extremely low-cost, biodegradable, and can be mixed with X-gal before extrusion [33]. Once
alginate hydrogel was selected as the sensor material, ionotropic gelation-based extrusion
emerged as the most cost-effective and easily manufacturable mechanism for producing the
biosensor. This project, in part, focuses on optimizing the size of spherical capsules produced
through ionotropic gelation.
3.4 Colorimetric Analysis
Previous teams obtained colorimetric images using mobile phone photography and analyzed
these images using ImageJ computer software. ImageJ returns RGB (red, green, blue) values  of
selected pixels in an image. Several pixels from each well plate were averaged and analyzed. The
blueness index was calculated as “the ratio between the B value for each well and the average of
the G and R values.”
3.5 Image Analysis Challenges
Aftering struggling with consistent image analysis due to background lighting changes, previous
teams developed a custom-built photography lightbox to minimize the effects of outside light.
The lightbox is constructed from black acrylic sheets, with an aperture at the top of the box for a
smartphone camera and an LED light unit inside the lightbox to illuminate the sample [34].
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Although the custom-built lightbox considerably improved the consistency of the lighting
in the images captured for colorimetric analysis, the existing method for image analysis was still
unable to differentiate between lower concentrations of bacterial contamination. Figure 3 shows
the correlation between color intensity (“blueness”) and bacterial concentration using the
imaging methods described above. Notice that 104 and 105 CFU/mL color intensity values were
statistically indistinguishable.
(a) (b)
Figure 2: Colorimetric ladders generated by previous teams to compare sensor sensitivity. Varying concentrations of
E. coli were induced with (a) DHBM and (b) whole bovine milk. We also used these same images to test our
colorimetric algorithm.
(a) (b)
Figure 3: Graphs depicting the calculated RGB ratio for various concentrations of E. coli induced with (a) DHBM
and (b) whole bovine milk.
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3.6 Lower Limit of Detection Challenges
Although previous work [3] has demonstrated the viability of the X-gal alginate hydrogel
detection method, the accepted lower limit of detection (LOD) requirement for bacterial
pathogens of 104 CFU/mL [6] has not been reliably achieved for E. coli in this system. The
senior design team that first used an alginate hydrogel system with X-gal and β-galactosidase
reported their lower LOD as 106 CFU/mL [33]. Optimizing various system parameters using
Taguchi designs allowed for a 102 CFU/mL lower LOD, however this LOD was binary. The
system could not differentiate between 102 and 103 CFU/mL, making it ineffective for rejecting
breast milk samples with 104 CFU/mL while accepting 103 CFU/mL [3]. Using an updated image
analysis mechanism, last year’s senior design team achieved a 104 CFU/mL lower LOD, but this
was only for pathogens in water [35]. It is imperative that MilkGuard consistently achieves a 104
CFU/mL (and ideally lower) LOD to be acceptable for usage at milk banks.
3.7 Rationale for Current Work
To address current challenges of the MilkGuard system, our project focuses on the development
of a computer-aided design (CAD) model, a simulation-aided geometry optimization, a
colorimetric analysis algorithm, and a mobile phone application. Our work aims to improve the
sensitivity and usability of the X-gal alginate hydrogel system to more precisely and accurately
detect E. coli in donated breast milk at milk banks. A realistic, dynamic CAD model allows for
cost-savings and waste-reduction compared to an equivalent amount of physical laboratory
experiments. The CAD model additionally allows for the easy collection and storage of
experimental data, and can be used, as demonstrated below, to optimize subsystems. Automating
colorimetric analysis with a computer algorithm programmed into a mobile application is a
reliable, cost-effective way to achieve highly sensitive results. Due to the prevalence of
smartphones, use of mobile phone applications in low-resource conditions is common [36-39],
and suggests that the MilkGuard system may be adapted in the future for use in such settings.
17
Chapter 4: Materials & Methods
4.1 MilkGuard Subsystems
To reach the target sensitivity of 104 CFU/mL, MilkGuard was split into two subsystems. First,
the optimization of the biosensor parameters would improve the color-producing efficacy of our
system, which would bring us closer to our goal. Computer simulations were determined to be
the most effective way to optimize the MilkGuard biosensor.
Another way to reach our target sensitivity was to improve the color-analysis component
of the MilkGuard system. A mobile application was developed to improve the ease of analysis.
The mobile application utilized a color-analysis algorithm that was improved upon to increase
sensitivity. Several approaches were considered, but the final improvements are listed in
following sections.
4.2 Simulation Materials
4.2.1 Chemical & Biological Reagents
E. coli strain SCU-104, Luria Bertani broth, N,N-Dimethylformamide, medium-viscosity
alginic acid, and β-galactosidase were purchased from Sigma-Aldrich (St. Louis, MI,
USA). The B-PER Direct Bacterial Protein Extraction Kit and X-gal were procured from
Thermo Fisher Scientific (Waltham, MA, USA). All other reagent grade chemicals were
provided by the Bioengineering Department at Santa Clara University, (Santa Clara,
California, USA). Further details and lot numbers are described in previous literature [3].
4.2.2 COMSOL Multiphysics
COMSOL Multiphysics v.5.5 was used to develop a 2D virtual model of our biosensor
based on parameters established in previous experiments. A space-dependent Transport
of Diluted Species module to model diffusion and a Chemistry module to model the





As described in detail in previous literature [3], E. coli were cultured, grown to
appropriate optical density (OD), and induced for lac operon expression using breast milk
samples. After incubating the breast milk-induced E. coli samples overnight, the bacteria
were harvested, resuspended, and used to create ladders of known bacterial
concentrations in breast milk. Samples were then lysed with B-PER protein extraction
solution to extract β-galactosidase from the E. coli.
The alginate hydrogel microcapsules were fabricated as described in section 3.2.
4.2.2 Simulation Geometry
The geometry in our simulation is a 2D representation of the alginate hydrogel biosensor
previously developed. A 2D simulation was chosen for reduced computational
complexity and for compatibility with available data. The spherical capsule alginate
hydrogel biosensor is represented by two concentric circles (“capsule”). The space
between the concentric circles is an explicitly defined reaction space (“membrane”).
Previous research [3] suggests that X-gal is sparingly or insoluble in breast milk. Thus,
the hydrolysis reaction of X-gal is isolated primarily to the surface of the hydrogel
capsule represented by the space between the concentric circles.
4.2.3 Simulation Parameters
A transport of diluted species model of existing biosensor data was created in COMSOL
Multiphysics v.5.5. The transport is governed by Fick’s Second Law of Diffusion, given
in Eq. 1.  Michaelis menten kinetics for enzymatic reactions given in Eq. 2 are used to
model the hydrolysis of X-gal. The reaction rate Ri from Eq. 2 is then substituted into the
reaction rate term Ri in Eq. 1 to yield Eq 3. Various model parameters are defined in Eq.
4. The gradient term in Eq. 1 is expanded and parameters from Eq. 4 are then substituted
into Eq 1 to yield Eq. 5
The terms in Eq. 5 can be rearranged to contain the Thiele Modulus for spherical
capsules given in Eq. 6. Substituting the Thiele Modulus for spherical capsules into Eq. 5
then yields Eq. 7.
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The Thiele modulus for spherical capsules relates the kinetic (V”m / Km), diffusive (De)
and geometric (R) parameters. While Eq. 7 can be used to effectively model diffusion, the
individual components of the Thiele modulus cannot be effectively experimentally
determined, and therefore cannot be used to effectively model the reaction velocity.
Instead, an alternative mechanism is used to relate kinetic, diffusive, and geometric
parameters. Data for Michaelis-Menten kinetics of the hydrolysis of X-gal with
β-galactosidase were collected for free, un-encapsulated X-gal. These experimentally
derived values Vm and Km are used to approximate the model’s kinetic parameters. To
account for the diffusion-limiting effect of X-gal encapsulation, values relating hydrogel
capsule radius r and the reduction in reaction velocity η (“effectiveness factor”) were
collected experimentally. MATLAB Curve Fitting was used to generate a relationship
between capsule radius and effectiveness factor η. The resulting curve is power function
where A = 0.2429, B = 0.1243, and C = 1.033. Figure 4 gives a model of the
effectiveness function. Thus, the complete reaction rate in the model is given by
20
Figure 4: Effectiveness constant as a function of capsule radius, from experimentally derived values.
The diffusion constants and initial concentrations in the model are given in Table 1.
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Table 1: Simulation inputs for COMSOL biosensor model.
X-gal blue precipitate
Dmembrane (m2/s) 1 x 10-12 (DA) 5 x 10-10 (DB)
Dcapsule (m2/s) 1 x 10-12 (DA) 5 x 10-10 (DB)
Dbulk (m2/s) 0 1 x 10-6
Initial concentrationmembrane (mol/m3) 1 0
Initial concentrationcapsule (mol/m3) 1 0
Initial concentrationbulk (mol/m3) 0 0
Mass balances around the control volume with membrane thickness δ are shown in Eq.
10 and Eq. 11.
There were no Dirichlet nor Neumann boundary conditions explicitly defined in the
COMSOL simulation to solve the transient concentration profiles. Rather, the boundary
conditions were driven by fluxes.
Since X-gal solubility is low in the aqueous bulk solution (breast milk), the bulk diffusion
coefficient was set to zero. This forced a zero flux condition at the outer membrane
interface. Although the reaction rate is a lumped rate of two-phase (solid substrate/liquid
enzyme) and one-phase (solubilized substrate/liquid enzyme) reaction mechanisms, the
rate was simplified in the model to assume the reaction rate occurs in one phase. The
two-phase system and insolubility of X-gal in the bulk solution are reflected in the
differences in substrate diffusivity between the membrane and capsule domain; X-gal




A geometry-optimization experiment was conducted with the completed COMSOL
model to develop a theoretical basis for future laboratory experiments. This model allows
this research team to streamline laboratory experimental trials to reduce the cost and
production of hazardous waste.
The optimization explored three variables: 1) the radius of each alginate hydrogel
capsule (“biosensor radius”), 2) the number of capsules per sample (“capsule count”), and
3) the total alginate hydrogel volume (“biosensor volume”). Capsule radii were varied
from 200 to 1,500 µm, approximately the range of microcapsules that can be reliably
produced with extrusion-based microfluidics. Capsule counts examined were 1, 5, 10,
and 25 capsules. Raising the capsule count above 25 results in long computation times
and lowers the cost-effectiveness of the manufacturing process. The optimization
examined total alginate hydrogel volumes of 1 µL, 10 µL, 20 µl, 30 µL, etc. up to a
maximum of 100 µL. A spherical alginate hydrogel biosensor geometry was retained
throughout the optimization for ease of production.
To reduce the total number of computations while maintaining investigative
results, a total biosensor volume was selected first. Then, the radii required to additively
achieve that total volume with 1, 5, 10 and 25 capsules were calculated. These radii
values were rounded to the nearest multiple of 5, based on the limitations of the level of
precision of extrusion-based coaxial jetting processes. All values tested in COMSOL are
provided in Table 2.
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Table 2: Radius values (µm, shown in white) tested in COMSOL, calculated to fit into specific volume categories
(light blue) for each capsule count (dark blue).
4.4 Mobile App Materials
A mobile application, Milkguard, was developed for Android smartphones. The Android
Operating System was chosen over Apple's iOS since Android devices are usually more
cost-effective [40], and are more widely available to our target consumers.
Since the app was implemented in the cross-platform React Native language, small
modifications to the source code would allow iPhone users to use the MilkGuard app as well
[41]. Besides being readily adaptable for both iOS and Android operating systems, the React
Native language is also the best choice for starting app development from scratch [42]. Its
combined simplicity, computational efficiency, and compatibility with JavaScript [43] make
React Native the ideal choice as our mobile application development language.
Most of the application features (buttons, navigation menu, and design & user interface
elements) were implemented from the Expo Software Development Kit [44], but the color
analysis software component was downloaded as a Native Module from npm.js [45]. The chosen
react-native-image-colors module was the most user-friendly and highest rated color
analysis module on the NPM open source repository [45].
The react-native-image-colors module returns RGB values for the selected portion of the
image by accessing the palette class on Android [46], and can return the “dominant,”
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“average,” “muted,” “vibrant,” color scheme for a selected image, but the Milkguard app
only uses the “average” result. The getColor() function averages every n pixels in the
selected image.
4.5 Mobile App Methods (long section)
4.5.1 RGB Color Balance
Since every brand of smartphone captures color slightly differently [47], our mobile
application performs color balance before continuing with colorimetric analysis. Humans
have a psychological ability to maintain color constancy in different lighting
environments [48], but computers require additional processing to do the same [49].
Several color balance algorithms exist, such as those for improving diagnosis via
color-stained tissue in anatomic pathology [50] for computer vision applications. The
MilkGuard app uses a simple linearization color balance algorithm designed for general
use [51]:
The returned RGB values display R = 255, G = 255, and B = 255 for the designated
standard white.
4.5.2 Conversion to HSL Color Space
We then convert the color balance from RGB to HSL (defined below) for improved
colorimetric analysis. Because the RGB color space was designed for the now-prevalent
tri-color LCD displays [52], it is the most common way to represent color digitally, but it
is not ideal for biological image analysis [53]. The RGB values are converted to HSL
according to the following algorithm [54]:
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In the HSL color space, HSL is an abbreviation for Hue, Saturation, Lightness (or
Luminance, or Luminosity). HSL is interchangeably known as HSB, which stands for
Hue, Saturation, Brightness, but the values are identical.
● Hue: identifies the base color, independent of shade or tone. In optics, hue is
directly correlated to the wavelength of light. Under white lighting circumstances,
adjusting the brightness does not affect the hue [55].
● Saturation: identifies the pureness and intensity of a color. As saturation
decreases, that color looks more and more like gray. A black and white image has
a saturation value of 0 (zero) [55].
● Lightness: identifies the brightness of a color. A lower value corresponds to a
color that is closer to black, and a higher value is closer to white [55].
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Figure 5: An HSL color cylinder model showing the corresponding dimensions for Hue, Saturation, and Lightness
[56].
The HSL color space is superior to RGB for color analysis, because RGB is often “unable
to produce sufficient information for Digital Image analysis” [57]. HSL provides the
most consistent numerical regression information [58], which our app needs. Other
colorimetric analysis diagnostic tools also prefer the HSL color space, such as an
algorithm for melanoma detection [59].
Finally, the HSL color space is more scientifically intuitive for our assay. In the
presence of E. coli, and therefore the β-Galactosidase enzyme, X-Gal is cleaved into
colorless galactose plus 5-bromo-4-chloro-3-hydroxyindole, which oxidized into
5,5'-dibromo-4,4'-dichloro-indigo. The indigo product has maximum absorbance at 650
nm, and thus it appears blue [60]. Against our white wellplate, differing concentrations of
the indigo-colored substrate directly affect the Saturation and Lightness of the sample
color, but not the Hue, since the reflectance and absorbance wavelength values of the
5,5'-dibromo-4,4'-dichloro-indigo do not change. Therefore, our color regression only
depends on the S and L of the HSL colorspace (the lightness/darkness and intensity of the
given 5,5'-dibromo-4,4'-dichloro-indigo blue). The RGB color space unnecessarily
complicates this relationship through varying proportions of the red, green, and blue
components of the sample color, which are not easy to decipher.
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4.5.3 HSL Distance
The obtained HSL values are then used to calculate the Euclidean distance between the
sample color and pure white. Since the identity of the target chemical product does not
change, Hue is assumed to hold constant. Thus the Euclidean distance is calculated from
the Lightness and Saturation components only.
Calculating the Euclidean distance in color spaces (including RGB [61]) is a
common technique to obtain single numerical results to be used in analytical regression
[62]. This technique is effective for small color differences, such as for determining the
level of tomato ripeness [63], but ineffective for large color differences [64]. Fortunately,
our app only needs to differentiate between various shades of blue which are relatively
close in the HSL color space.
The logarithm of calculated distance value is obtained to consolidate range. Then, the
transformed color distance values are plotted against E. coli concentrations. The same




5.1.1 Comparison to Experimental Results
The generated COMSOL model reflects behavior observed in experimental data. In
laboratory experiments, visualization of X-gal with phase-contrast microscopy showed
that X-gal crystal concentration appears to decrease only near the surface of the
microcapsules after 2 hours of reaction time. Additionally, the intensity of the blue
precipitate continues to increase up to around 24 hours of incubation [65]. This suggests
that the diffusion of X-gal through the hydrogel capsule is relatively slow, and that X-gal
concentration at the center of the capsules should not change much throughout the six
hour simulation. Parameters were selected to maintain initial X-gal concentration of 1
g/m3 at the center of capsules of 1500 µm radii. For capsules of smaller radii
(approximately <700 µm) the concentration at the center of the bead begins to decrease
by six hours of reaction time.
Figure 6 shows bisected hydrogel capsules removed from breast milk samples
spiked with E. coli after specific incubation times are shown with corresponding frames
from the COMSOL model. Capsules removed and bisected after about 5 minutes of
incubation show no visible blue precipitate. After 30 minutes of incubation, a light hue is
observed at the surface of the capsule with a very faint hue present at the center of the
capsule. After 60 minutes of incubation, precipitate concentration has become more
uniform throughout the capsule.
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Figure 6: Comparison of experimental data and COMSOL model surface concentration outputs for blue reaction
precipitate. a) Experimental after 30 mins incubation, b) COMSOL output at 30 minutes reaction time, c)
Experimental after 60 mins incubation, d) COMSOL output at 60 minutes reaction time. Figure 6a and 6c from
Madamba, 2019 [65].
5.1.2 Geometry Optimization
The simulation results suggest that the reaction progression is most efficient (i.e. when
blue color change for a given volume of X-gal/alginate hydrogel capsule is most rapid) in
capsules with smaller radii. In other words, if total capsule volume is fixed, the system’s
time-to-result decreases when that total volume is divided up into a greater number of
capsules (see Figure 7). This trend was observed across all time indices and for all fixed
capsule volumes.
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Figure 7: Reaction precipitates concentration in milk samples (i.e. outside of the biosensor capsule) as a function of
capsule radius at selected time indices. The total capsule volume is held constant at 50 μLfor all data points in this
figure. Capsule radii are varied with fixed capsule volume by modulating the number of capsules used per sample.
From left to right, capsules counts for corresponding radii values are 25, 10, 5, and 1 capsules per sample. The
results suggest that spherical capsules with smaller radii have the most efficient reaction progression.
When capsule count is held equal and volume is varied by modulating capsule
radius, greater total capsules volumes produce the most rapid color change (see Figure 8).
This finding was consistent across all capsule counts.
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Figure 8: Reaction precipitate concentration over time for capsules of selected radii. Results indicate that greater
total capsule volumes produce more rapid results.
Taken together, the geometry simulation suggests that ideal biosensor geometry
for this system would be a high number of alginate hydrogel capsules (and therefore high
total biosensor volume) with the smallest radii that can be reasonably manufactured. The
total capsule volume will be limited by the cost of X-gal. The size of the capsule radii
will be limited by manufacturing costs.
5.1.3 Future Work
More research is needed to determine more precise diffusivity constants for the
transportation of X-gal and the blue reaction precipitate product. Once determined, these
values can easily be added to the COMSOL model. In-lab experiments, informed by the
results of the COMSOL model, should be performed to confirm biosensor geometry
optimization. The results of in-lab experiments should then be considered against
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material and manufacturing cost considerations to produce a product that is sensitive,
rapid, and affordable for breast milk banks.
The existing COMSOL model can be iterated to incorporate additional factors
that potentially impact bacteriological results. For example, it was determined that
alginate hydrogel bulk degradation was negligible over the time period studied in this
application [66], but degradation may become an important variable to include if the
hydrogel material is altered to reach the required lower limit of detection [6].
5.2 Color Analysis / Mobile App Results
Images of colorimetric ladders obtained from previous teams are shown in Figure 2. The
corresponding HSL values are marked on the HSL color cylinder model. As predicted by theory,
Hue stays relatively constant, while Saturation and Lightness vary, producing points that lie on a
line, which can be analyzed via obtaining the color distance value.
Figure 9: Induced blue color represented on the HSL color space cylinder model for (a) 104 CFU/mL, (b) 105
CFU/mL, (c) 106 CFU/mL, (d) 107 CFU/mL, (e) 108 CFU/mL. (f) All concentrations shown, with the black circle
representing pure white.
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The combination of colorimetric analysis strategies yielded the following graphical
results, as seen in Figure 10.
(a) (b)
Figure 10: Graphs depicting the calculated Color Distance Values for various concentrations of E. coli induced with
(a) DHBM and (b) whole bovine milk. Image data obtained from previous MilkGuard Team’s laboratory results.
The two graphs demonstrate differentiable colorimetric sensitivity from 104–107 CFU/mL range.
See further analysis on the graphs in Section 6.2.
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Figure 11: Graph depicting the calculated Color Distance Value for various concentrations of E. coli induced with
DHBM in clear wellplates. Image data obtained from previous MilkGuard Team’s laboratory results (n = 3).
The graph above demonstrates differentiable colorimetric sensitivity between 104 and 105
CFU/mL, and beyond 106 CFU/mL. See further analysis on the graphs in Section 6.2.
Figure 12 shows a series of screenshots that depicts the workflow of the MilkGuard app,
which makes it intuitive for the user to access the color-analysis algorithm described above.
From the home screen (a) the user can choose to view history or run a test. After the instructions
screen (b), the user chooses an image to analyze from images stored in local memory (not
shown) or from the in-app camera (c). The user then chooses a specific area of the selected
picture (d) to analyze by moving the corners of the box to focus on the area of interest. The
confirmation page (f) allows the user to check the image quality before proceeding. Steps (b–f)
are repeated for choosing the “Standard White” for color balance (selection of standard white not
shown). The results screen (g) displays the bacterial concentration. The user can edit the date of
the sample and include extra notes for reference, before storing into history (h). Steps (a–g) are
repeated for a new milk sample.
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Figure 12: Diagram showing screenshots from the MilkGuard app. (a) Home screen with options to run a test or see
history of tests. (b) Instructions screens with options to obtain image via camera or image library. (c) Screenshot of
camera. (d) Selection box for focusing on area of interest. (e) Selection box correctly placed over color. (f)
Confirmation screen shows selected image to be analyzed. (g) Results screen with options to change or enter
information. (h) History screen with information on previous test results.
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Chapter 6: Discussion and Recommendations
6.1 Biosensor Simulation & Optimization
COMSOL simulation of biosensor parameters provided a low-cost method to optimize
MilkGuard’s color-producing speed and efficacy. Through the rounds of simulations, we
discovered that biosensor capsules with greater volume produce more rapid results, which faster
detection of E. coli contamination. More rapid results can also be observed by increasing the
surface area of the biosensor, with all other factors held constant, which can be achieved by
dividing the biosensor hydrogel into as many portions of micro-encapsulated spheres as
manufacturing technologies allow. Future teams would have to find an optimization between
biosensor volume and individual size to achieve the goals of MilkGuard, while staying within the
constraints of chemical reagent and manufacturing costs.
Perhaps the most significant contribution of COMSOL simulation is the proof of concept
that computer-aided modeling could be used to optimize for the MilkGuard sensor. Running
simulations on a computer is much more economical and environmentally friendly than
producing hundreds or thousands of physical sensors with varying parameters, and testing each
one. Costs have been especially reduced in avoiding the use of X-gal in physical sensors, due to
the high cost of the reagent. By running simulations, instead of producing, testing, then disposing
of multiple batches of biosensors, production of hazardous waste has been avoided. We have
built a simulation framework that future teams can utilize to further improve on the
color-producing efficacy of the MilkGuard sensor. The simulation gives MilkGuard the
information and tools to effectively and efficiently create a product that achieves our required
lower limit of detection to improve the health and safety of infants.
6.2 Mobile App & Color Analysis Algorithm
The addition of several algorithmic improvements to the previous team’s color-analysis
algorithm resulted in more sensitive and consistent results. Figure 13 compares the graphical
results of last year's and this year's color analysis algorithm. The two algorithms were applied to
the exact set of images, but they yielded different results. When comparing the results of
analyzing the 3D printed white well plate (Figure 2), we can see a difference between the graphs
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of this year and last year, for both the DHBM and whole bovine milk images. In the graph from
last year, we see an insignificant difference between the 104 and 105 CFU/mL values. However,
our new algorithm yielded a noticeable difference between those two values, and presented
linearity between 104 and 107 CFU/mL values, which is very useful for building linear regression
curves.
Figure 13: Graphs depicting the calculated color values for various concentrations of E. coli induced with (a) whole
bovine milk, analyzed using previous algorithm, (b) whole bovine milk, analyzed using new algorithm, (c) DHBM,
analyzed using previous algorithm, (d) DHBM, analyzed using new algorithm. Analysis performed on the same set
of image data obtained from previous MilkGuard Team’s laboratory results.
In analyzing the series of clear well plates (not shown), our new algorithm also increased
the sensitivity in our region of interest (104 CFU/mL). Whereas the previous algorithm yielded
an insignificant difference between 103 and 104 CFU/mL values, our new algorithm shows a
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significant difference, as indicated by the error bars. The increased sensitivity of our new
algorithm around the target region (the HMBANA’s recommended lower limit of detection
standard of 104 CFU/mL) shows the improved efficacy of our system. The improved detection of
low but still potentially harmful concentrations of E. coli in DHBM at milk banks may promote
the health of infants who need a safe milk source.
Figure 14: Graphs depicting the calculated color values for various concentrations of E. coli induced with DHBM in
clear wellplates (a) before and (b) after applying color balance, HSL conversion, and color-distance regression.
Analysis performed on the same set of image data obtained from previous MilkGuard Team’s laboratory results (n =
3).
The development of the mobile app greatly simplifies the process of colorimetric analysis
for the end user. Before, the user would need to take a picture of the resulting milk sample,
upload the image onto a computer, use the ImageJ software to obtain the RGB values, and
calculate the color intensity ratio before comparing it with the standardized regression curve.
This was a complicated process. With the app, the milk bank technician can now perform all
these tasks right on a smartphone within minutes, guided by the instructions and workflow
provided by the app. The app contains a user interface that is minimalistic and attractive to use,
and the buttons are big and easy to tap. The mobile app is a product that could be highly
distributable via Apple App Store or the Google Play Store. Altogether, the MilkGuard app
greatly increases the usability of the milk system and removes obstacles the user may face when
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trying to utilize our novel color analysis algorithm. We are hopeful that this improvement
increases the accessibility of our product to milk banks in need.
6.3 Cost Considerations
The system discussed in this paper may offer milk banks a cost-effective alternative to the
current practice of bacteriological testing at external laboratories [67]. Estimates of assay cost
vary based on biosensor geometry, X-gal concentration, and B-PER bacterial extraction
concentration but all yield cost-per-sample estimates of less than $1. This suggests that the
MilkGuard technology could significantly reduce the costs of bacteriological testing at milk
banks, which currently range from $35-81 per 100-200 oz of breastmilk [8]. Multiple studies
[68-70] have documented the cost-effectiveness of point-of-care testing, particularly when
testing mechanisms are low-cost and reliable.
6.4 Next Steps
6.4.1 Remaining Challenges
Despite our accomplishments this year, there are still important improvements to be made
on the MilkGuard System. Through processes described above, both the biosensor
geometry and improved image analysis algorithm developed this year bring MilkGuard
closer to achieving the HMBANA’s 104 CFU/mL lower limit of detection requirement.
However, due to the lack of lab access this year, we have not been able to physically test
and confirm whether the suggested geometry optimization and algorithmic improvements
will consistently allow us to reach this level of sensitivity. Similarly, a related challenge
remains—that of achieving consistent lighting while capturing images of milk samples.
Previous teams have developed a light box as described in Section 3.5. However, we have
yet to test whether that will still be necessary, given our implementation of the
color-balancing algorithm. Future teams must perform tests on a large number of samples
to confirm that it will adequately provide consistent image analysis in a low-resources
setting. Otherwise, the light box will continue to be required as part of the MilkGuard
system.
A few challenges were not addressed in this paper. The MilkGuard team had
observed a batch-to-batch variation in β-galactosidase expression in E. coli. In other
40
words, different strains of E. coli produce different quantities of β-galactosidase, the
enzyme that reacts with X-gal in our assay. Batch-to-batch variation could make it
difficult to correlate blue precipitate concentration with E. coli concentration, but the
effects of this variation may be negligible. Another probable explanation for the observed
batch-to-batch variation in β-galactosidase is a batch-to-batch variation in the lactose
concentration in breast milk. It is well-known that the nutrients found in breast milk vary
from mother to mother [71,72]. Breast milk with higher lactose expression may cause
enhanced induction of the lac operon, which may cause enhanced expression of
β-galactosidase. Further investigation is needed to determine whether additional controls
or assay components are necessary to achieve consistently accurate results.
A final challenge for future teams to address is the supposed necessity of an
incubator for sample testing. In the current MilkGuard protocol, milk samples should be
placed under incubation at 37℃ after the alginate hydrogel biosensor is added. This
protocol exists because of previous work suggesting that 37℃ produces the most rapid
color change results [3]. However, with optimal biosensor geometry, benchtop reactions
may be sufficient in low-resources settings where incubation is unavailable. Whether this
is possible remains to be tested in-lab.
6.4.2 Immediate Next Steps
Immediate next steps consist of confirming the results of the geometry optimization
experiment performed virtually in COMSOL Multiphysics once labs are again readily
available. At this time, it will also be important that future MilkGuard teams collect more
data with both cow’s and human breast milk to test the accuracy of the MilkGuard
algorithm and app. Observations from this data will additionally help future teams
investigate the impact of batch-to-batch β-galactosidase expression discussed above.
After the app is tested with more in-lab data, it will need to be pilot tested at milk
banks and improved for usability. We want the app to be usable with minimal training so
that milk bank technicians can seamlessly transition to in-house bacteriological testing.
Feedback from pilot testing will be crucial to achieving this goal. Related to the goal of
usability, an additional immediate next-step is to determine whether or not bacterial lysis
with B-PER bacterial extraction solution is necessary to reach the required lower limit of
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detection. Removing this step from the MilkGuard assay (see section 4.2.1) would greatly
increase the usability of our product. Given the high cost of bacterial extraction reagents,
excluding bacterial lysis would also decrease the cost per sample for MilkGuard.
6.4.3 Long Term Next Steps
After the biosensor geometry and assay are optimized, the lower limit of detection is
consistently reached, and batch-to-batch variabilities are addressed, future reams will
need to focus on pilot testing of the MilkGuard system at breast milk banks.
Concurrently, future teams should focus on the logistics of scaling-up the manufacturing
process while keeping product cost low.
Milk banks are the target customer base for the MilkGuard project. Thus, the
needs of milk banks are of primary consideration at our current stage of development.
That said, we envision MilkGuard becoming a product that could be marketed directly to
mothers who desire to ensure the milk they are giving their infants is free of pathogens.
Long term, we hope to increase the usability of MilkGuard even further so that it can be
used by consumers without training.
If the model for bacteriological testing of E. coli presented in this paper proves to
be accurate, sensitive, low-cost, and highly usable, we hope to expand the system to
additional pathogens commonly found in donated human breast milk, such as strains of
Streptococcus and Staphylococcus, and Bacillus [73] . Incorporating tests for multiple
bacteriological pathogens in one system would allow milk banks to further cut production
costs, further expanding infant access to optimal nutrition.
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Chapter 7: Ethics and Engineering Standards
7.1 Ethical Justification
Achieving infants’ equitable access to human breast milk is a worthwhile goal because of the
significant potential impact that early-life breastfeeding could have on children. To lower the
barrier to infants’ access to breastmilk would be to promote the health and safety of infants
worldwide. The MilkGuard system has the potential to make a lasting and significant impact on
the availability of DHBM to infants whose mothers cannot provide breast milk. Once fully
functional and distributable, MilkGuard has the potential of greatly increasing the operating
efficiency at milk banks.
The MilkGuard project pushes the boundaries of biotechnology. Currently, there are no
existing affordable, intuitive, and rapid diagnostic devices for DHBM. In the process, our
biosensor optimization and mobile application development incorporated state-of-the-art
technologies. The resulting product aims to bring about great service and benefit to our primary
stakeholders—milk banks for DHBM. Other stakeholders in our project include the mothers and
infants who are in need of DHBM. These are vulnerable populations who will benefit from the
success of our project. With the full optimization and development of MilkGuard, we can serve
milk banks, infants, and mothers in need. In this manner, the MilkGuard project encourages us to
become engineers who approach our profession with competence, conscience, and compassion.
By lowering the cost of the bacterial assay of breast milk, we make the process more
accessible. By developing a user-friendly smartphone application for the process, we simplify the
job of milk bank technicians and thus lower the entry barrier for this position. By running
computer simulation for the optimization of biosensor parameters, we pave the way for the ease
of improvement of future teams. By improving on the color analysis algorithm, we improve the
sensitivity and consistency of our detection method, which contributes to detecting the lower, yet
still harmful levels of bacterial contamination in DHBM.





As described in section 6.3, MilkGuard offers milk banks a more affordable way to
conduct bacteriological testing that is necessary for optimal infant health. In-house
bacteriological testing at milk banks provides a “point-of-care” model that has the
potential to reduce the cost of donated human breast milk.
7.2.2 Manufacturability
The alginate hydrogel biosensor capsules used in the MilkGuard biosensor can be easily
manufactured at industrial scale. The selection of spherical alginate hydrogel geometry
greatly increases the viability of mass production, as microfluidic extrusion using coaxial
needles is widely used in biotechnology manufacturing. Using a mobile app for image
analysis “increases” the manufacturability of our product in the sense that little
manufacturing is needed for image analysis. The MilkGuard app can be widely
distributed given the global prevalence of smartphones. Though this year’s MilkGuard
team did not focus on the use or production of the lightbox used for smartphone image
capture, we are aware that the lightbox is an additional component of the MilkGuard
system that will need to be custom manufactured. Future teams could consider finding a
comparable 3rd party option for image analysis to eliminate the need to contract through
an additional production plant.
7.2.3 Health & safety
Literature research suggests that rigorous bacteriological testing increases the safety of
donated human breast milk [3]. Thus, affordable, efficient testing methods are crucial to
improving the health and safety of infants who would not otherwise have access to
human breast milk. Our efforts throughout the past year have moved MilkGuard one step
closer to offering milk banks a system that is affordable, efficient, and sensitive enough
to detect HMBANA’s lower limit of detection standard of 104 CFU/mL [2].
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7.2.4 Usability
A key consideration during the mobile app development was that it be highly usable by
milk bank technicians. Using a mobile application for image analysis, rather than
requiring milk banks technicians to master additional image analysis tools, decreases the
duration of training required to use MilkGuard and suggests that our system may be
usable in lower resource settings internationally.
7.2.5 Environmental impact
The alginate hydrogel sensor used in MilkGuard is readily biodegradable, biocompatible,
and biointert [74]. Thus, the disposal of waste produced during testing with MilkGuard
should not cause environmental harm. Furthermore, the X-gal product used to detect E.
coli via reaction with beta-galactosidase has no hazardous classifications on the Globally
Harmonized System of Classification and Labelling of Chemicals [75]. However, when
dissolved in dimethylformamide (DMF), X-gal powder’s safety classification increases to
“harmful”. Since the existing MilkGuard protocol utilizes DMF, future MilkGuard teams
may want to consider dissolving X-gal in a solution with a more favorable safety rating,
both for the health of the environment and for the health of milk bank technicians, who
are unlikely to be working in chemical safety hoods.
7.2.6 Social
The big picture goal of MilkGuard is to lower barriers to infant access to breast milk.
Increasing access to donated human breast milk through low-cost bacteriological testing
that can potentially be used in low-resource settings may lower infant mortality rates
[76]. Though not necessarily causal, lower infant mortality rates are correlated with lower
income inequality [77] and greater political gender equity [78]. While we cannot
guarantee that MilkGuard will create a more socially equitable society, our efforts to




In the US, the Food and Drug Administration officially recommends the use of DHBM
under the direction of a physician [79]. The FDA does not directly regulate milk banks.
Instead, the Human Milk Banking Association of North America (HMBANA) provides
milk banks with regulatory standards [80]. Our efforts to achieve a 104 CFU/mL lower
limit of detection requirement are based on HMBANA’s official recommendations.
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Chapter 8: Conclusions
Fast, affordable and accurate methods of testing breast milk for breast milk banks is crucially
needed throughout the world, and the MilkGuard system was developed to address that. Previous
team had achieved a low-cost biosensor that produces results in approximately four hours. Yet at
the beginning of this year, MilkGuard was unable to achieve the HBMANA’s lower limit of
detection standard of 104 CFU/mL, and the assay process was difficult and unintuitive.
To reach this bacterial contamination detection level, we explored two methods:
improving the MilkGuard biosensor and developing a better color analysis system.
By running COMSOL simulations while varying several parameters, we discovered the
optimal geometry for MilkGuard biosensors—high volume and high surface area. Future teams
would need to confirm this in physical laboratories, while keeping the manufacturing and
chemical reagent costs relatively low. Our series of COMSOL simulations prove the possibility
of realistically optimizing biosensors in a computer-based simulation environment, which is
more economical and environmentally friendly than building hundreds of physical biosensors to
test. We also developed a simulation platform that future teams can use to further improve on the
MilkGuard biosensor.
By developing the MilkGuard app, we have allowed the user to easily utilize our new
color analysis algorithm for the colorimetric determination of E. coli contamination levels. Our
algorithm uses color balance, HSL conversion, and color-distance regression to improve
sensitivity around the target contamination level of 104 CFU/mL. Future teams would need to
confirm the effectiveness of our algorithm with in-lab testing, and build a more robust linear
regression curve based on a larger sample size. Our improved detection sensitivity means better
breastmilk testing for better infant health.
This year, our testing and developments have improved the MilkGuard system. With our
developments, testing breast milk with MilkGuard is now easier and more sensitive than before.
Through our simulations, we have also provided a way for future teams to improve the biosensor
even more. Through our team’s contribution to MilkGuard, we have striven towards infants’
equitable access to breastmilk, as we try to achieve a more humane, just and sustainable world
through bioengineering innovation. We look forward to when MilkGuard is fully optimized and
functional as it improves infant health around the world.
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10.1 Team Members and Roles
Emma McCurry: Lead Contact Person, Simulation and Geometry Optimization Lead
Emma served as the lead contact person for the project, submitting various official documents
and handling correspondence with Santa Clara University’s School of Engineering. Before the
team pivoted to a fully virtual senior design project, Emma created experimental protocols and
timelines for lab-based work. After the pivot, Emma learned to use COMSOL Multiphysics and
created a realistic computed-aided design simulation of the MilkGuard biosensor. Emma
designed, executed, and analysed the COMSOL biosensor geometry optimization experiment.
Beau Hsia: Mobile Application and Colorimetric Algorithm Developer, Visual Design Lead
Beau served as the MilkGuard mobile application developer, coding the app from scratch (while
self-learning the React Native app programming language through the process). Beau also
improved upon last year’s color-analysis algorithm through the addition of color balance, HSL
colorspace conversion, and color-distance calculation and regression, methods he discovered
through research and experimentation. Additionally, Beau designed the MilkGuard logo and
colorway, which were uniformly implemented in the smartphone application and in the Senior
Design Presentation package.
10.2 Key Acronyms and Abbreviations
B-PER = Bacterial Protein Extraction Reagent
CC = Microfluidic Capillary Circuit
CFU = Colony Forming Units
CFU/mL = Colony Forming Units per milliliter
COMSOL = Not an acronym, but a program title. COMSOL Multiphysics software
DHM = Donor Human Milk or Donated Human Breast Milk
DMF = Dimethylformamide
FDA= Food and Drug Administration
GHS = Globally Harmonized System of Classification and Labelling of Chemicals
HMBANA = Human Milk Banking Association of North America
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HSL = Hue, Saturation, Lightness (or Luminance, or Luminosity) (Color space model)
IEEE = Institute of Electrical and Electronics Engineers
IPTG = Isopropyl β-ᴅ-1-thiogalactopyranoside
LOD = Limit of Detection
OD = Optical Density
RGB = Red, Green, Blue (Color space model)
WHO = World Health Organization
X-Gal = 5-bromo-4-chloro-3-indolyl-β-ᴅ
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